Can you make a CRISPR Golden Rice?

golden-rice-about2

Golden Rice may be the best agricultural product from the biotech era before CRISPR. Unfortunately it’s caught in the GMOs redtape, and authorizations for commercial growing are still missing 17 years after its invention. This rice engineered to biosynthesize β-carotene could save lives and improve the health of people struggling with vitamin A deficiency in several regions of the world. If policymakers and consumers will give a warmer response to genome editing, in comparison with classic genetic engineering, could CRISPR solve the impasse by allowing the development of a new non-GM Golden Rice? We asked its inventors, Ingo Potrykus and Peter Beyer.

Continue reading

Oldie but goodie. Sanjaya Rajaram speaks out

Sanjaya_Rajaram_WFPHe does not write pamphlets with easy recipes for a better world. He has spent more time in the fields than captivating audiences. However, it is a symptom of a cultural disease that few people know Sanjaya Rajaram – and many know Vandana Shiva. This former is an Indian agronomist, who won the 2014 World Food Prize, has picked up the torch of Nobel Peace Prize winner Norman Borlaug, father of the Green Revolution who, in the second half of the last century, doubled grain production in much of the globe, as a result of better seeds, irrigation, fertilizers and pesticides. Rajaram has developed 500 new varieties of wheat grown in 51 countries. He came to Italy for the World Food Research and Innovation Forum promoted by the Emilia Romagna region. Continue reading

Germany debates CRISPR

leopoldina

Germany stands out as the European country most interested in fostering an informed debate on CRISPR many uses. Today an interdisciplinary group of experts from the German National Academy of Sciences (Leopoldina) has published a Discussion Paper entitled “Ethical and legal assessment of genome editing in research on human cells”.  Experiments involving human embryos are prohibited by law in the country but the document suggests a possible compromise. Research should be permitted on “orphaned” embryos created for reproductive purposes but no longer going to be used for reproduction. In February the German academy co-organized a meeting on edited plants, discussing what kind of regulation would be suitable. In 2005 they published a statement on “The opportunities and limits of genome editing” and another one on molecular plant breeding. According to a Leopoldina official press-release, the annual assembly “will be intensively addressing the topic of genome editing” later this year.

Six questions for the YouTuber singing CRISPR

The best explanations of CRISPR ever heard in 413 words, or 4 minutes and half of listening, is not an article from a prestigious science journal but a YouTube video where the wonders of the new technique of genetic modification are sung a cappella. We couldn’t not interview the author. Tim Blais was a fresh physics graduate when he turned its science-music into a professional activity by means of crowdfunding. That about CRISPR is probably his best video and has quickly become viral.    Continue reading

Light bulb or bomb?

 

augias bomba atomicaCRISPR ’s debut in the cultural programming of the Italian television occurred at “Quante storie”, a 30 minutes book show aired by the public broadcasting company (Rai 3, 23 March 2017). It went with a genuine interest into understanding the science of genome editing and many questions from the classic repertoire concerning biotechnology, from worries about economic interests at play (but if we want drugs, the pharma industry must be there) to the risk of using the new technique for eugenics purposes (the long shadow of Nazism still makes us think blond children would be favored). Continue reading

Edited crops, organic farming and Greenpeace Mag

fiblThe German publication Greenpeace Magazin interviewed Urs Niggli, the director of FiBL, a leading research institute on organic agriculture. In his opinion genome editing is going to be useful and edited crops should not be classified as GMOs but assessed on a case by case basis. The text below by Frauke Ladleif was translated and posted with the kind permission of Greenpeace Magazin/Hamburg. Continue reading

Editing cancer at IEO

pelicci quadrotto

The second leg of the journey among leading labs takes us to the European Institute of Oncology in Milan. CRISPR’s potential is particularly exciting for oncology, as tumors are caused by multiple mutations and the new technique of genome editing is multiplexable, meaning it may target several genes at the same time. IEO scientific co-director Pier Giuseppe Pelicci has shared his enthusiasm with us.

“In our lab we are using CRISPR in 3 broad research areas. In the first area we follow the classic way, by disrupting the genes we want to study in order to understand their functions. CRISPR can do it much better than the previous techniques. It’s fast, very cheap and easy to handle. Before CRISPR we could carry out an experiment every 6 months, after CRISPR we can do one every week. It’s like altering the flow of time.” Continue reading

News review: edited crops in Science and Nature

news reviewThis week the royal couple of science journals have turned  the spotlight on CRISPR’s potential for agriculture. “Genome editors take on crops” and “CRISPR, microbes and more are joining the war against crop killers” are the titles respectively chosen by Science and Nature. The first one is a perspective by Armin Scheben and David Edwards from the University of Western Australia. “Improved crops are urgently needed to meet growing demand for food and address changing climatic conditions”, they write. The global population is expected to rise from 7.3 to 9.7 billion by 2050 and a global increase in crop production of 100 to 110% from 2005 levels will be required. Continue reading

The art of learning from microbes

ecoli-1184pxBy Antonio Polito

Do you remember Dolly, the sheep cloned 20 years ago? I was one of the many going on pilgrimage to visit her in its golden prison at the Roslin Institute, near Edinburgh. And like other reporters I was worried while talking with Dolly’s “father” Ian Wilmut, about practical and ethical implications of the breakthrough, which appeared huge at the time. Media were boiling with awe and outrage: is human cloning the next step? It would be evil or blessing? Are we playing God?  Continue reading

Targeting Huntington at CattaneoLab

huntingtonCRISPR is radically changing the way researchers work, by allowing better, faster, and cheaper experiments. This blog will tell, among other things, how leading labs are using the most popular technique for genome editing. Let the dance begin with the Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases of the University of Milan (CattaneoLab). The group directed by Elena Cattaneo is busy unveiling the molecular basis of neurodegeneration in Huntington’s disease with the help of CRISPR, as pharmacologist Chiara Zuccato explains.

Continue reading